Read more: Evidation Collaborates with Merck on Digital Monitoring Study on Alzheimer’s Disease

←Back to news

The Adoption of Digital Measures in Healthcare

July 2021

 

Digital measures, derived using computational methods from at-home monitoring technologies, including wearables and smartphones, offer a range of benefits. These include objective, continuous insights into patient behavior and physiology that are unencumbered by recall effects observed in subjective, patient-reported tools. Digital measures also provide a way to detect intermittent/rare events or create novel measures that more sensitively assess patient experience.

Read More.

 

  • The Playbook: Digital Clinical Measures| Digital Medicine Society (DiMe)

How can the industry successfully develop and deploy digital clinical measures and remote monitoring? Are there resources that meet specific needs and expertise? Read More.

  • Digitizing Clinical Trials | npj

Digital MedicineDigital clinical trials leverage digital technology to improve participant access, engagement, trial-related measurement and interventions, etc. How can we implement the use of digital technologies in clinical trials considering there are challenges? Read More.

 

Other Good Reads:

FDA Approves New Use of Transplant Drug Based on Real-World Evidence | FDA

Top 5 Trends in Digital Health | TechRepublic 

Doctors Might Have Been Focusing on the Wrong Asthma Triggers | The Atlantic 

5 Healthcare Innovation Trends to Keep a Close Eye On | Becker’s Health IT

 

What We’ve Been Up To:

Announcement: Digital measures have the potential to make visible what is currently clinically visible. We are proud to collaborate with Merck to study and identify digital endpoints for use in Alzheimer’s drug development. Our initial study will explore consented real-world data from smartphones and wearable devices from elderly individuals with and without cognitive impairment. Together, we are committed to better understanding, diagnosing, and treating Alzheimer’s disease at its earliest detectable stages. Read More. 

Research: At Evidation, we assessed the feasibility of collecting data from multiple smart devices of older adults with and without cognitive impairment, and tested whether the data from these devices can differentiate between healthy individuals and participants with cognitive impairment. Read More.

Research: What is “post-COVID syndrome” and how can leveraging the patient perspective and technological innovations enable the delineation of effective treatments? Read More

On-Demand Panel Discussion: Want to understand the importance of digital measures in evidence generation and generating engagement? Evidation’s Ieuan Clay joined the SBHD Conference panel to discuss generating person-generated health data (PGHD). Watch Here.

Heart Health on Achievement: In our nationwide Heart Health on Achievement initiative focusing on the lived experience of individuals with heart failure beyond the clinic walls, we compared self-reported trends in overall health with objective behavioral data collected from consumer-grade wearables. It was found that people who reported feeling better tend to have increased their activity levels over the preceding few months. In addition to activity trends, we also explored medication and access issues. Read More

Get To Know Your Evidation Team: Meet Solomon Howard – a member on the Diversity Equity & Inclusion team on Evidation’s platform. Read More.

Further reading